NYSE Celebrates 5 Years of Amador

Exciting news! 🎉 Last month, we marked our 5th anniversary, and the New York Stock Exchange joined in the celebration by showcasing us on the trading floor. We are truly grateful to the NYSE for this recognition. 👏

Since our founding in May 2018 in Pleasanton, California, Amador has evolved into one of the top global CROs, offering comprehensive services in translational and quantitative clinical pharmacology, bioanalysis, biomarkers, pharmacovigilance, biostatistics, and clinical development. We're proud to have assisted over 200 pharmaceutical companies in developing innovative drugs across China, the US, Europe, and Japan. 🌍🚀 With operational sites and GxP bioanalytical laboratories in key locations like Pleasanton, Germantown, Ann Arbor, Hangzhou, Shanghai, Beijing, and Limburg, we've built a strong global team and are well-equipped to continue driving advancements in new drug development.

Stay tuned for more news of our 5-year celebrations! 🥳

Want to learn more?